Benjamin Zadik
Technical Writer and Techincal Writing

The file you have chosen is a PDF and requires Adobe Reader.

PDFClick here to download: White Paper (PDF)


Business Interface Groups (BIG)
Business Showcase + LifeScience: Drugs, Bugs & Devices

Event details:
Panel Discussion: “What's Hot And What's Not For 2007”
Location: Cooley Godward LLP
3175 Hanover Street, Palo Alto, CA 94304
Date: Thursday, January 18
Time: 7:00–8:30 pm

Where we are: 2006 wrap-up

Moderator Frank Rahmani began with a brief presentation about the overall investment climate in the past several years and looking forward to 2007. He showed that overall investment is up since the dotcom bust where investment fell from $94.8 billion in 2000 to just $36.4 billion in 2001. Investment has been steady for the past 3 years and looks to continue that way in the foreseeable future. A breakdown of where the money is going shows that, on average, about one-third of overall investment dollars have been going to healthcare companies. Divided further by category, 62% goes to biopharmaceuticals, 2% to healthcare services, 32% medical devices, and 4% medical IS (data from 3rd Quarter 2006). When looking at IPOs, there was a marked up tick in 2006 that may be the result of a backlog that will move into 2007. Trends also show that companies are older—on average healthcare and biopharm companies reach 5–6 years before being acquired.